about
Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-cultureMesenchymal Stem/Stromal Cells in Stromal Evolution and Cancer ProgressionVersican overexpression in human breast cancer lesions: known and new isoforms for stromal tumor targetingExpression of the FGFR1 gene in human breast-carcinoma cellsSTAT3 can be activated through paracrine signaling in breast epithelial cells.Involvement of breast epithelial-stromal interactions in the regulation of protein tyrosine phosphatase-gamma (PTPgamma) mRNA expression by estrogenically active agents.Human breast fibroblasts inhibit growth of the MCF10AT xenograft model of proliferative breast disease.Interactions between tissue fibroblasts in lymph nodes and Hodgkin/Reed-Sternberg cells.Proliferative behaviour of an oestrogen sensitive rat mammary tumour: evidence for a paracrine interaction between tumour and stromaFibroblast stimulation of breast cancer cell growth in a serum-free system.Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblastsHuman breast cancer cells contain a phosphoramidon-sensitive metalloproteinase which can process exogenous big endothelin-1 to endothelin-1: a proposed mitogen for human breast fibroblasts.Short-term primary culture of epithelial cells derived from human breast tumoursExpression of keratinocyte growth factor and its receptor in human breast cancer.Selective interactions between epithelial tumour cells and bone marrow mesenchymal stem cellsEstablishment of a human pro-B cell line (JKB-1) and its differentiation of preestablished bone marrow stromal cell layer.Differential regulation of breast tumor cell proliferation by stromal fibroblasts of various breast tissue sources.Hormonally responsive breast cancer cells in a microfluidic co-culture model as a sensor of microenvironmental activity.Urokinase-type-plasminogen-activator (uPA) production by human breast (myo) fibroblasts in vitro: influence of transforming growth factor-beta(1) (TGF beta(1)) compared with factor(s) released by human epithelial-carcinoma cells.Elevated expression of cyclooxygenase-2 in breast cancer and ductal carcinoma in situ has no correlation with established prognostic markers.Hodgkin's lymphoma cells are efficiently engrafted and tumor marker CD30 is expressed with constitutive nuclear factor-kappaB activity in unconditioned NOD/SCID/gammac(null) mice.Prompt tumor formation and maintenance of constitutive NF-kappaB activity of multiple myeloma cells in NOD/SCID/gammacnull mice.M(R) 77 KDA factor derived from fibroblasts stimulates the invasion ability of breast-cancer cells.Cytokines facilitate chemotactic motility of breast carcinoma cells.Tenascin-C matrix assembly in oral squamous cell carcinoma.Primary human fibroblasts induce diverse tumor invasiveness: involvement of HGF as an important paracrine factor.Metastasis from human breast cancer cell lines.Interleukin-3: a putative protective factor against breast cancer which is secreted by male but not female breast fibroblasts.Mutual paracrine effects of colorectal tumour cells and stromal cells: modulation of tumour and stromal cell differentiation and extracellular matrix component production in culture.Hexadecylphosphocholine differs from conventional cytostatic agents.Effects of lymphocytes and fibroblasts on the growth of human mammary carcinoma cells studied in short-term primary cultures.Enhancement of antiproliferative effects of interleukin-1beta and tumor necrosis factor-alpha on human prostate cancer LNCaP cells by coculture with normal fibroblasts through secreted interleukin-6.Phenotypic heterogeneity in breast fibroblasts: Functional anomaly in fibroblasts from histologically normal tissue adjacent to carcinoma
P2860
Q24796529-8A9E5E2C-A747-472A-9ADB-35E3CFB0459FQ26770002-B4F11CDB-0791-47CE-BE83-0776AE29B96AQ28254157-04E8E1E3-ED04-407F-8F12-B16F0EDEC812Q28609135-766839CA-046C-4D96-A8EB-C53FCA8CCAF2Q30849602-459F1C8B-05BD-4FE2-AEE4-1058B74FD64EQ34115488-DEDDFCDA-058E-4EC9-97BF-166BAB61506AQ35781431-38AB38DD-BB01-4811-A09F-C7F81D94E267Q35820996-6ACB2D04-85A9-49B1-A97F-AEAA7B654BAEQ35975868-29F7DEAB-F569-492C-8686-2FB9A4918435Q35976977-3F96307A-4B3A-4AB6-9A88-EE0829D2B745Q35977847-C6C2D884-B39A-4413-A8AC-BC0F7BE51F6EQ36080476-186EAE45-F3C6-4869-AE7F-B79054E1E439Q36115787-EFFBA3C3-F0C8-42AA-B424-CD41B88A113DQ36421770-E292D10E-AEA8-4C93-8B53-2C2F797ADFE8Q36641652-A36B83E8-E752-4B26-8C91-533CE591D06AQ36748920-C192A216-4B0D-48A9-A6E2-2E65695DF7FDQ36789076-36355FFD-0C3E-45A7-840C-064C008A5C56Q36827824-96D9BDBA-8626-49B8-A539-6F1264AF04ACQ36897082-64AD8125-A447-4E17-B23C-E50856B573EAQ38445530-9C85634E-E7FD-418E-948C-D18122FFF7EEQ40383844-638ADA4C-F947-4B97-9D98-A6F76F959BA3Q40537551-B7CBED02-0F89-4964-9972-A48CD877095AQ40814283-2092883A-9974-492B-8C2D-6D29C1E3489FQ40849411-EC3B071A-4E01-4080-A69C-A3EC1878C41AQ41060748-8B7EB88E-9102-4CD4-B254-7E38DAA44DBEQ41152341-5081C609-705F-412C-A026-7E8179E3E5A2Q41251300-E0DD2979-9FB9-4872-B58B-170713F0F359Q41347209-8DF2E3E5-B172-425F-A290-AAC46312CB59Q53355929-8DACCEB5-B81B-4B5F-9771-92D24935A06DQ53483873-CE4204A5-B35F-4E63-A6DC-66C7E62576D8Q54104292-918265F9-4AB4-464C-B9FD-421519BD472AQ55333263-92C90672-70A0-41CE-9932-9BF425C6F27CQ59289398-CF285647-D345-41BA-9446-930C0B920E1F
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Stromal influences on breast cancer cell growth.
@ast
Stromal influences on breast cancer cell growth.
@en
Stromal influences on breast cancer cell growth.
@nl
type
label
Stromal influences on breast cancer cell growth.
@ast
Stromal influences on breast cancer cell growth.
@en
Stromal influences on breast cancer cell growth.
@nl
prefLabel
Stromal influences on breast cancer cell growth.
@ast
Stromal influences on breast cancer cell growth.
@en
Stromal influences on breast cancer cell growth.
@nl
P2093
P2860
P356
P1476
Stromal influences on breast cancer cell growth.
@en
P2093
Claassen C
Eggermont AM
Foekens JA
Henzen-Logmans SC
van Ooijen B
van Roozendaal CE
P2860
P2888
P356
10.1038/BJC.1992.14
P407
P577
1992-01-01T00:00:00Z
P5875
P6179
1008804173